Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial

Vincent C. Marconi; Athimalaipet V. Ramanan; Stephanie de Bono; Cynthia E. Kartman; Venkatesh Krishnan; Ran Liao; Maria Lucia B. Piruzeli; Jason D. Goldman; Jorge Alatorre-Alexander; Rita de Cassia Pellegrini; Vicente Estrada; Mousumi Som; Anabela Cardoso; Sujatro Chakladar; Brenda Crowe; Paulo Reis; Xin Zhang; David H. Adams; E. Wesley Ely

bioRxiv (2021) - Comments
doi: 10.1101/2021.04.30.21255934

Vincent C. Marconi, Athimalaipet V. Ramanan, Stephanie De Bono, Cynthia E. Kartman, Venkatesh Krishnan, Ran Liao, Maria Lucia B. Piruzeli, Jason D. Goldman, Jorge Alatorre-Alexander, Rita De Cassia Pellegrini, Vicente Estrada, Mousumi Som, Anabela Cardoso, Sujatro Chakladar, Brenda Crowe, Paulo Reis, Xin Zhang, David H. Adams, E. Wesley Ely